| Firm | Analyst Name |
|---|---|
|
Guggenheim Securities
|
Vamil Divan, MD, MBA
|
|
Jefferies
|
Dennis Ding
|
|
JPMorgan
|
Ekaterina Knyazkova
|
|
Piper Sandler
|
David Amsellem
|
|
Raymond James
|
Transitioning
|
|
Truist Securities
|
Les Sulewski
|
|
H.C. Wainwright
|
Brandon Folkes
|
|
Leerink Partners
|
Thomas Smith
|
|
Barclays
|
Glen Santangelo
|
ANI Pharmaceuticals, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding ANI Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ANI Pharmaceuticals, Inc. or its management. ANI Pharmaceuticals, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.